Rheumatic disease treatment drugs, there are roughly control, symptomatic treatment, biologic drugs, as follows: the first category, the control of the disease drugs: such drugs can fundamentally alleviate the patient’s rheumatic disease progress, while the need for long-term use, commonly used are methotrexate, leflunomide, diacetin and febuxostat and other drugs. The choice of drugs should be based on the specific cause of the patient’s rheumatism to develop an individualized program. The second category, symptomatic anti-inflammatory and pain-relieving drugs: the most common of such drugs are non-steroidal pain-relieving drugs, such as erexib and ibuprofen, which are non-steroidal pain-relieving drugs, and also glucocorticoids, for anti-inflammatory and pain-relieving treatment. The third category, biological agents: biological agents for rheumatic diseases, fast-acting and effective, but relatively expensive. Before use, hepatitis, tuberculosis and neoplastic diseases must be strictly excluded before they can be used.